EntryPoint Capital’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$313K Buy
+2,083
New +$227K 0.08% 535
2026
Q1
Sell
-2,474
Closed -$253K 810
2025
Q4
$253K Buy
+2,474
New +$221K 0.1% 433
2025
Q1
Sell
-16,337
Closed -$499K 770
2024
Q4
$499K Sell
16,337
-15,296
-48% -$430K 0.21% 106
2024
Q3
$726K Buy
+31,633
New +$895K 0.41% 6
2024
Q2
Sell
-3,632
Closed -$74.9K 1582
2024
Q1
$74.9K Buy
+3,632
New +$77.9K 0.07% 564

Other funds holding GH

EntryPoint Capital's GH Position: Q2 2026 in Review

EntryPoint Capital opened a new position in Guardant Health (GH) in Q2 2026: 2,083 shares worth $313K. The stake represents 0.08% of the portfolio and ranks #535 among its holdings. This is a return to the name: EntryPoint Capital previously reported a position in GH as recently as Q4 2025.

EntryPoint Capital first reported a position in GH in Q1 2024 and has held it in 5 quarters since. The position peaked at $726K in Q3 2024. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • EntryPoint Capital held 2,083 shares of Guardant Health worth $313K as of Q2 2026.
  • Guardant Health was a new EntryPoint Capital position in Q2 2026.
  • Guardant Health made up 0.08% of EntryPoint Capital's portfolio in Q2 2026, its #535 holding.
  • EntryPoint Capital first reported a position in Guardant Health in Q1 2024 and has held it in 5 quarters since.
  • EntryPoint Capital's Guardant Health position peaked at $726K in Q3 2024.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.